Cover Image
Market Research Report

Europe Women's Health Diagnostics Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 910525
Published Content info 180 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Women's Health Diagnostics Market: Industry Trends and Forecast to 2026
Published: August 1, 2019 Content info: 180 Pages
Description

Europe women's health diagnostics market is projected to register a healthy CAGR in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Diagnostic Devices (Imaging and Monitoring Systems, Biopsy Devices, Reagents and Kits, Biomarkers, Others), End User (Hospitals, Diagnostic and Imaging Centers, Clinics, Home Care Setting), Country (Germany, France, U.K., Italy, Spain, Russia, Switzerland, Netherlands, Belgium, Turkey and rest of Europe).

Some of the major factors contributing to the growth of Europe women's health diagnostics market:

  • Rising prevalence of infectious diseases such as urinary tract infection and hepatitis among women
  • Increasing awareness about the health concerns among people

Key Market Players

The key market players for Europe women's health diagnostics market are listed below:

  • Siemens
  • Hologic, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Abbott
  • BD
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Koninklijke Philips N.V.
  • NeuroLogica Corp.
  • Shimadzu Corporation
  • bioMerieux SA
  • Carestream Health
  • MEDGYN PRODUCTS, INC.
  • URIT MEDICAL ELECTRONIC CO., LTD, COOK
  • Cardinal Health, PerkinElmer Inc.
  • GENERAL ELECTRIC
  • Quest Diagnostics Incorporated
  • Danaher, Sysmex Corporation
  • Hitachi, Ltd., Canon Inc.
  • FUJIFILM Holdings Corporation
  • Others
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR VENDOR SHARE ANALYSIS
  • 2.8 MULTIVARIATE MODELING
  • 2.9 PRODUCTS LIFELINE CURVE
  • 2.10 SECONDARY SOURCES
  • 2.11 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 INCREASING GERIATRIC FEMALE POPULATION
    • 3.1.2 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES
    • 3.1.3 INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES
    • 3.1.4 GROWING NUMBER OF DIAGNOSTIC DEVICE MANUFACTURING COMPANIES
  • 3.2 RESTRAINTS
    • 3.2.1 PRODUCT RECALLS OF VARIOUS COMPANIES
    • 3.2.2 HIGH COST OF DIAGNOSTIC PRODUCTS
  • 3.3 OPPORTUNITIES
    • 3.3.1 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTIC EQUIPMENT
    • 3.3.2 STRATEGIC INITIATIVES BY VARIOUS COMPANIES
  • 3.4 CHALLENGES
    • 3.4.1 UNACCEPTABLE HEALTH DISPARITIES IN THE U.S.
    • 3.4.2 PRICING PRESSURE
    • 3.4.3 INCREASING ADOPTION OF REFURBISHED DIAGNOSTIC IMAGING SYSTEMS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES

  • 6.1 OVERVIEW
  • 6.2 IMAGING AND MONITORING SYSTEMS
    • 6.2.1 MAMMOGRAPHY SYSTEMS
      • 6.2.1.1 DEVICES
        • 6.2.1.1.1 DIGITAL MAMMOGRAPHY SYSTEMS
        • 6.2.1.1.2 BREAST TOMOSYNTHESIS
        • 6.2.1.1.3 ANALOG MAMMOGRAPHY SYSTEMS
      • 6.2.1.2 APPLICATIONS
        • 6.2.1.2.1 BREAST LUMPS OR TUMORS
        • 6.2.1.2.2 BREAST CANCER
        • 6.2.1.2.3 OTHERS
    • 6.2.2 ULTRASOUND IMAGING SYSTEMS
      • 6.2.2.1 DEVICES
        • 6.2.2.1.1 OB/GYN ULTRASOUND
        • 6.2.2.1.2 BREAST ULTRASOUND
      • 6.2.2.2 APPLICATIONS
        • 6.2.2.2.1 PREGNANCY SCAN
        • 6.2.2.2.1.1 FETAL DEVELOPMENT
        • 6.2.2.2.1.2 FETAL ABNORMALITIES
        • 6.2.2.2.1.3 OTHERS
        • 6.2.2.2.2 PELVIC SCAN
        • 6.2.2.2.2.1 ABNORMAL PERIODS
        • 6.2.2.2.2.2 CYSTS
        • 6.2.2.2.2.3 FIBROIDS
        • 6.2.2.2.2.4 OTHERS
        • 6.2.2.2.3 ABDOMINAL SCAN
        • 6.2.2.2.4 OTHERS
        • 6.2.2.2.4.1 BREAST SCANS
        • 6.2.2.2.4.2 MUSCULOSKELETAL SCANS
        • 6.2.2.2.4.3 INTERNAL STRUCTURES
    • 6.2.3 MRI SYSTEMS
      • 6.2.3.1 APPLICATIONS
        • 6.2.3.1.1 BREAST SCAN
        • 6.2.3.1.2 ABDOMEN SCAN
        • 6.2.3.1.3 JOINTS SCAN
        • 6.2.3.1.4 SPINAL CORD SCAN
        • 6.2.3.1.5 CARDIAC SCAN
        • 6.2.3.1.6 BLOOD VESSELS SCAN
        • 6.2.3.1.7 OTHERS
    • 6.2.4 FERTILITY MONITORS
      • 6.2.4.1 APPLICATIONS
        • 6.2.4.1.1 OVULATION
        • 6.2.4.1.2 INFERTILITY
        • 6.2.4.1.3 PREGNANCY
        • 6.2.4.1.4 HORMONAL IMBALANCE
        • 6.2.4.1.5 OTHERS
    • 6.2.5 BONE DENSITOMETER
      • 6.2.5.1 APPLICATIONS
        • 6.2.5.1.1 OSTEOPOROSIS
        • 6.2.5.1.2 BONE-RELATED PROBLEMS
        • 6.2.5.1.3 RHEUMATOID ARTHRITIS
    • 6.2.6 NUCLEAR IMAGING SYSTEMS
      • 6.2.6.1 APPLICATIONS
        • 6.2.6.1.1 OSTEOARTHRITIS
        • 6.2.6.1.2 HEART DISEASE
        • 6.2.6.1.3 UROLOGICAL PROBLEMS
        • 6.2.6.1.4 GYNECOLOGICAL CANCERS
        • 6.2.6.1.5 MULTIPLE SCLEROSIS
        • 6.2.6.1.6 ALZHEIMER'S DISEASE
        • 6.2.6.1.7 THYROID DISEASE
        • 6.2.6.1.8 SEXUALLY TRANSMITTED INFECTIONS
        • 6.2.6.1.9 STROKE
        • 6.2.6.1.10 POST-TRAUMATIC STRESS DISORDER (PTSD)
        • 6.2.6.1.11 LUPUS
        • 6.2.6.1.12 OTHERS
    • 6.2.7 OTHERS
  • 6.3 BIOPSY DEVICES
    • 6.3.1 BIOPSY FOR CANCER
      • 6.3.1.1 BREAST CANCER
      • 6.3.1.2 CERVICAL CANCER
      • 6.3.1.3 OVARIAN CANCER
      • 6.3.1.4 OTHERS
    • 6.3.2 BREAST LUMPS BIOPSY
    • 6.3.3 BLOOD BIOPSY
      • 6.3.3.1 CANCEROUS
      • 6.3.3.2 NON-CANCEROUS
    • 6.3.4 LYMPH NODES BIOPSY
    • 6.3.5 THYROID BIOPSY
    • 6.3.6 SKIN BIOPSY
    • 6.3.7 OTHERS
  • 6.4 REAGENTS AND KITS
    • 6.4.1 PREGNANCY AND FERTILITY TESTING KITS
      • 6.4.1.1 PREGNANCY
      • 6.4.1.2 OVULATION
      • 6.4.1.3 OTHERS
    • 6.4.2 BLOOD TEST TYPE KIT
      • 6.4.2.1 OSTEOPOROSIS
      • 6.4.2.2 BLOOD CHEMISTRY & BLOOD CELL COUNT
      • 6.4.2.3 OTHERS
    • 6.4.3 HEPATITIS TESTING KIT
    • 6.4.4 TUMOR MARKER ELISA TEST KIT
    • 6.4.5 STD TEST KITS
      • 6.4.5.1 HIV TESTING
      • 6.4.5.2 HUMAN PAPILLOMAVIRUS (HPV) TESTING
      • 6.4.5.3 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING
      • 6.4.5.4 OTHERS
    • 6.4.6 PAP SMEAR TEST KIT
    • 6.4.7 MRSA TESTING KITS
    • 6.4.8 HORMONE MARKERS ELISA KITS
    • 6.4.9 TUBERCULOSIS TEST KIT
    • 6.4.10 OTHERS
  • 6.5 BIOMARKERS
    • 6.5.1 ONCOLOGY
      • 6.5.1.1 BREAST CANCER
      • 6.5.1.2 CERVICAL CANCER
      • 6.5.1.3 OVARIAN CANCER
      • 6.5.1.4 OTHERS
    • 6.5.2 PREGNANCY COMPLICATIONS
    • 6.5.3 INFECTIOUS DISEASES
    • 6.5.4 CARDIOVASCULAR DISEASES
    • 6.5.5 OTHERS
  • 6.6 OTHERS

7 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 HOSPITALS
  • 7.3 DIAGNOSTIC AND IMAGING CENTERS
  • 7.4 CLINICS
  • 7.5 HOME CARE SETTING

8 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY GEOGRAPHY

  • 8.1 EUROPE
    • 8.1.1 GERMANY
    • 8.1.2 FRANCE
    • 8.1.3 U.K.
    • 8.1.4 ITALY
    • 8.1.5 SPAIN
    • 8.1.6 RUSSIA
    • 8.1.7 SWITZERLAND
    • 8.1.8 NETHERLANDS
    • 8.1.9 BELGIUM
    • 8.1.10 TURKEY
    • 8.1.11 REST OF EUROPE

9 EUROPE BIOPSY DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE

  • 9.1 COMPANY SHARE ANALYSIS: EUROPE

10 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN'S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE

  • 10.1 COMPANY SHARE ANALYSIS: EUROPE

11 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN'S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE

  • 11.1 COMPANY SHARE ANALYSIS: EUROPE

12 EUROPE MRI SYSTEM IN WOMEN'S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE

  • 12.1 COMPANY SHARE ANALYSIS: EUROPE

13 COMPANY PROFILE

  • 13.1 HOLOGIC INC
    • 13.1.1 COMPANY SNAPSHOT
    • 13.1.2 REVENUE ANALYSIS
    • 13.1.3 COMPANY SHARE ANALYSIS
    • 13.1.4 PRODUCT PORTFOLIO
    • 13.1.5 RECENT DEVELOPMENTS

  • 13.2 SIEMENS
    • 13.2.1 COMPANY SNAPSHOT
    • 13.2.2 REVENUE ANALYSIS
    • 13.2.3 COMPANY SHARE ANALYSIS
    • 13.2.4 PRODUCT PORTFOLIO
    • 13.2.5 RECENT DEVELOPMENTS
  • 13.3 GENERAL ELECTRIC
    • 13.3.1 COMPANY SNAPSHOT
    • 13.3.2 REVENUE ANALYSIS
    • 13.3.3 COMPANY SHARE ANALYSIS
    • 13.3.4 PRODUCT PORTFOLIO
    • 13.3.5 RECENT DEVELOPMENT
  • 13.4 KONINKLIJKE PHILIPS N.V.
    • 13.4.1 COMPANY SNAPSHOT
    • 13.4.2 REVENUE ANALYSIS
    • 13.4.3 COMPANY SHARE ANALYSIS
    • 13.4.4 PRODUCT PORTFOLIO
    • 13.4.5 RECENT DEVELOPMENTS
  • 13.5 HITACHI, LTD.
    • 13.5.1 COMPANY SNAPSHOT
    • 13.5.2 REVENUE ANALYSIS
    • 13.5.3 COMPANY SHARE ANALYSIS
    • 13.5.4 PRODUCT PORTFOLIO
    • 13.5.5 RECENT DEVELOPMENTS
  • 13.6 FUJIFILM HOLDINGS CORPORATION
    • 13.6.1 COMPANY SNAPSHOT
    • 13.6.2 REVENUE ANALYSIS
    • 13.6.3 COMPANY SHARE ANALYSIS
    • 13.6.4 PRODUCT PORTFOLIO
    • 13.6.5 RECENT DEVELOPMENTS
  • 13.7 ABBOTT
    • 13.7.1 COMPANY SNAPSHOT
    • 13.7.2 REVENUE ANALYSIS
    • 13.7.3 PRODUCT PORTFOLIO
    • 13.7.4 RECENT DEVELOPMENTS
  • 13.8 BD
    • 13.8.1 COMPANY SNAPSHOT
    • 13.8.2 REVENUE ANALYSIS
    • 13.8.3 PRODUCT PORTFOLIO
    • 13.8.4 RECENT DEVELOPMENTS
  • 13.9 BIOMERIEUX SA
    • 13.9.1 COMPANY SNAPSHOT
    • 13.9.2 REVENUE ANALYSIS
    • 13.9.3 PRODUCT PORTFOLIO
    • 13.9.4 RECENT DEVELOPMENT
  • 13.10 BIOMERIEUX SA
    • 13.10.1 COMPANY SNAPSHOT
    • 13.10.2 REVENUE ANALYSIS
    • 13.10.3 PRODUCT PORTFOLIO
    • 13.10.4 RECENT DEVELOPMENT
  • 13.11 CANON INC.
    • 13.11.1 COMPANY SNAPSHOT
    • 13.11.2 REVENUE ANALYSIS
    • 13.11.3 PRODUCT PORTFOLIO
    • 13.11.4 RECENT DEVELOPMENTS
  • 13.12 CARDINAL HEALTH
    • 13.12.1 COMPANY SNAPSHOT
    • 13.12.2 REVENUE ANALYSIS
    • 13.12.3 PRODUCT PORTFOLIO
    • 13.12.4 RECENT DEVELOPMENT
  • 13.13 CARESTREAM HEALTH
    • 13.13.1 COMPANY SNAPSHOT
    • 13.13.2 PRODUCT PORTFOLIO
    • 13.13.3 RECENT DEVELOPMENT
  • 13.14 COOK
    • 13.14.1 COMPANY SNAPSHOT
    • 13.14.2 DIVISION PORTFOLIO
    • 13.14.3 RECENT DEVELOPMENTS
  • 13.15 DANAHER
    • 13.15.1 COMPANY SNAPSHOT
    • 13.15.2 REVENUE ANALYSIS
    • 13.15.3 PRODUCT PORTFOLIO
    • 13.15.4 RECENT DEVELOPMENTS
  • 13.16 F. HOFFMANN-LA ROCHE LTD.
    • 13.16.1 COMPANY SNAPSHOT
    • 13.16.2 REVENUE ANALYSIS
    • 13.16.3 PRODUCT PORTFOLIO
    • 13.16.4 RECENT DEVELOPMENTS

  • 13.17 MEDGYN PRODUCTS, INC
    • 13.17.1 COMPANY SNAPSHOT
    • 13.17.2 PRODUCT PORTFOLIO
    • 13.17.3 RECENT DEVELOPMENT
  • 13.18 NEUROLOGICA CORP.
    • 13.18.1 COMPANY SNAPSHOT
    • 13.18.2 PRODUCT PORTFOLIO
    • 13.18.3 RECENT DEVELOPMENTS
  • 13.19 PERKINELMER INC.
    • 13.19.1 COMPANY SNAPSHOT
    • 13.19.2 REVENUE ANALYSIS
    • 13.19.3 PRODUCT PORTFOLIO
    • 13.19.4 RECENT DEVELOPMENT
  • 13.20 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 13.20.1 COMPANY SNAPSHOT
    • 13.20.2 PRODUCT PORTFOLIO
    • 13.20.3 RECENT DEVELOPMENTS
  • 13.21 SHIMADZU CORPORATION
    • 13.21.1 COMPANY SNAPSHOT
    • 13.21.2 REVENUE ANALYSIS
    • 13.21.3 PRODUCT PORTFOLIO
    • 13.21.4 RECENT DEVELOPEMNT
  • 13.22 SYSMEX CORPORATION
    • 13.22.1 COMPANY SNAPSHOT
    • 13.22.2 REVENUE ANALYSIS
    • 13.22.3 PRODUCT PORTFOLIO
    • 13.22.4 RECENT DEVELOPMENT
  • 13.23 THERMO FISHER SCIENTIFIC INC.
    • 13.23.1 COMPANY SNAPSHOT
    • 13.23.2 REVENUE ANALYSIS
    • 13.23.3 PRODUCT PORTFOLIO
    • 13.23.4 RECENT DEVELOPMENTS
  • 13.24 URIT MEDICAL ELECTRONIC CO., LTD
    • 13.24.1 COMPANY SNAPSHOT
    • 13.24.2 PRODUCT PORTFOLIO
    • 13.24.3 RECENT DEVELOPMENT

14 CONCLUSION

15 SWOT ANALYSIS AND DBMR ANALYSIS

  • 15.1 SWOT ANALYSIS
  • 15.2 DATA BRIDGE MARKET RESEARCH ANALYSIS

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 RESEARCH AND DEVELOPMENT (USD MILLION)
  • TABLE 2 MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 3 MIDDLE EAST & AFRICA IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 4 MIDDLE EAST & AFRICA IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 5 MIDDLE EAST & AFRICA MAMMOGRAPHY SYSTEMS DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE, 2017-2026 (USD MILLION)
  • TABLE 6 MIDDLE EAST & AFRICA APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
  • TABLE 7 MIDDLE EAST & AFRICA ULTRASOUND IMAGING SYSTEMS DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
  • TABLE 8 MIDDLE EAST & AFRICA APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
  • TABLE 9 MIDDLE EAST & AFRICA PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
  • TABLE 10 MIDDLE EAST & AFRICA PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
  • TABLE 11 MIDDLE EAST & AFRICA OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
  • TABLE 12 MIDDLE EAST & AFRICA APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
  • TABLE 13 MIDDLE EAST & AFRICA APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
  • TABLE 14 MIDDLE EAST & AFRICA BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
  • TABLE 15 MIDDLE EAST & AFRICA APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
  • TABLE 16 MIDDLE EAST & AFRICA BIOPSY DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 17 MIDDLE EAST & AFRICA BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
  • TABLE 18 MIDDLE EAST & AFRICA BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
  • TABLE 19 MIDDLE EAST & AFRICA BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
  • TABLE 20 MIDDLE EAST & AFRICA REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 MIDDLE EAST & AFRICA REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 22 MIDDLE EAST & AFRICA PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 23 MIDDLE EAST & AFRICA BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 24 MIDDLE EAST & AFRICA STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 25 MIDDLE EAST & AFRICA BIOMARKERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 MIDDLE EAST & AFRICA BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
  • TABLE 27 MIDDLE EAST & AFRICA ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
  • TABLE 28 MIDDLE EAST & AFRICA OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 30 MIDDLE EAST & AFRICA HOSPITALS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 MIDDLE EAST & AFRICA DIAGNOSTIC AND IMAGING CENTERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32 MIDDLE EAST & AFRICA CLINICS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 33 MIDDLE EAST & AFRICA HOME CARE SETTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 34 MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 35 MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 36 MIDDLE EAST & AFRICA IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 37 MIDDLE EAST & AFRICA MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 38 MIDDLE EAST & AFRICA APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 39 MIDDLE EAST & AFRICA ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 40 MIDDLE EAST & AFRICA APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 41 MIDDLE EAST & AFRICA PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 42 MIDDLE EAST & AFRICA PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 43 MIDDLE EAST & AFRICA OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 44 MIDDLE EAST & AFRICA APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 45 MIDDLE EAST & AFRICA APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 46 MIDDLE EAST & AFRICA APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 47 MIDDLE EAST & AFRICA BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 48 MIDDLE EAST & AFRICA BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 49 MIDDLE EAST & AFRICA BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 50 MIDDLE EAST & AFRICA BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 51 MIDDLE EAST & AFRICA BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 52 MIDDLE EAST & AFRICA ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 53 MIDDLE EAST & AFRICA REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 54 MIDDLE EAST & AFRICA PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 55 MIDDLE EAST & AFRICA BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 56 MIDDLE EAST & AFRICA STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 57 MIDDLE EAST & AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 58 SOUTH AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 59 SOUTH AFRICA IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 60 SOUTH AFRICA MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 61 SOUTH AFRICA APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 62 SOUTH AFRICA ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 63 SOUTH AFRICA APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 64 SOUTH AFRICA PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 65 SOUTH AFRICA PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 66 SOUTH AFRICA OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 67 SOUTH AFRICA APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 68 SOUTH AFRICA APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 69 SOUTH AFRICA APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 70 SOUTH AFRICA BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 71 SOUTH AFRICA BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 72 SOUTH AFRICA BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 73 SOUTH AFRICA BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 74 SOUTH AFRICA BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 75 SOUTH AFRICA ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 76 SOUTH AFRICA REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 77 SOUTH AFRICA PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 78 SOUTH AFRICA BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 79 SOUTH AFRICA STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
  • TABLE 80 SOUTH AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 81 REST OF MIDDLE EAST AND AFRICA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: SEGMENTATION
  • FIGURE 2 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: DROC ANALYSIS
  • FIGURE 4 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: EUROPE VS REGIONAL ANALYSIS
  • FIGURE 5 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 EUROPE BIOPSY DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 8 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN'S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 9 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN'S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 10 EUROPE MRI SYSTEM IN WOMEN'S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET
  • FIGURE 12 PERCENT DISTRIBUTION OF THE 10 LEADING CAUSES OF DEATH IN WOMEN: UNITED STATES, 2017
  • FIGURE 13 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: SEGMENTATION
  • FIGURE 14 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES AND INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES ARE EXPECTED TO DRIVE THE EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 15 IMAGING AND MONTORING IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 16 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES, 2018
  • FIGURE 17 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: BY END USER, 2018
  • FIGURE 18 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: SNAPSHOT (2018)
  • FIGURE 19 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018)
  • FIGURE 20 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 21 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 22 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES (2019-2026)
  • FIGURE 23 EUROPE BIOPSY DEVISE IN WOMEN'S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 24 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN'S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 25 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN'S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 26 EUROPE MRI SYSTEM IN WOMEN'S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
Back to Top